logo-loader

Medlab Clinical forges ahead in new vitamin trials for chronic illnesses

Last updated: 23:30 07 May 2019 EDT, First published: 09:30 07 May 2019 EDT

Medlab Clinical Ltd (ASX:MDC) chief executive officer Sean Hall tells Proactive Investors how the company is tapping into new areas of its “therapeutic toolkit” to better assist those with chronic health conditions.
 
Hall says there has been a shortfall in the standard of quality healthcare today and Medlab is looking to provide better new health solutions.
 
The company is doing extensive work exploring the role gut health plays in chronic illnesses and developing quality nutraceuticals, popular treatments that contributed towards Medlab's revenue milestones last month.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

5 minutes ago